In an age of increasingly personalized healthcare, Elizabeth Philp has become a leading figure of innovation, especially in the tech-driven field of compounded pharmacy. As the chief executive and co-founder of Roseway Labs, Philp is at the vanguard of a push to make custom medications more available, disrupting the conventional one-size-fits-all